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Abstract The evidence that nitric oxide (NO) production is
possible by a non-enzymatic pathway has already been shown
under restrictive experimental conditions. Here we show that NO
can non-enzymatically be formed with short-time kinetics (min),
by ‘bombing’ with shock waves a solution containing 1 mM
hydrogen peroxide and 10 mM L-arginine. This procedure is
widening its medical application with surprisingly positive
effects in tissue regeneration and our finding could be one of
the first steps for the understanding of the biochemical
responsible for these therapeutical effects. ) 2002 Published
by Elsevier Science B.V. on behalf of the Federation of Euro-
pean Biochemical Societies.
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1. Introduction
A shock wave (SW) [1] consists of an acoustic wave that
generates a pressure impulse during 0.1^0.2 ms and is capable
of determining a pressure gradient between +100 and 310
Mpa. Conveyed by an appropriate generator to a speci¢c
target area (focal area), the power created can be modulated
in the range of 0.003^0.890 mJ/mm2. In the last 15 years the
clinic use of this technique has been signi¢cantly enlarged,
especially for kidney and urinary calculus lithotripsy. Techno-
logical evolution in energy level control and in target area
focusing has improved the clinical results, reducing at the
same time undesired side-e¡ects. Besides this ‘primary’ use,
a few years ago a secondary anti-in£ammatory e¡ect in ten-
don and muscle tissues [2] and a complete recovery even in
pseudoarthrosis pathologies were detected [2^5]. In particular,
treatment of the tendon and muscle tissues was found to in-
duce a long-time (1^4 months) tissue regeneration e¡ect [5,6],
besides a more immediate anthalgic and anti-in£ammatory
e¡ect. This regenerative pathway seems to involve free radical
production and revascularization events taking place in the
SW-treated area [6].
Our idea is that one of the most important molecules in-
volved in these therapeutic e¡ects might be nitric oxide (NO).
NO, normally produced in eukaryotes from L-arginine by dif-
ferent isoforms of NO synthase (NOS), exerts a potent and
immediate vasodilatory action and modulates the subsequent
angiogenesis [7,8]. Based on the evidence that the vasodilatory
e¡ect detectable in the area treated with SW is almost imme-
diate, we decided to start our studies in an in vitro system, to
verify ¢rst of all whether SW application could induce rapid
and non-enzymatic formation of NO.
Information describing that NO can be produced without
the catalytic activity of NOS has been already reported [9^12].
It includes both the non-enzymatic in vivo formation of NO
due to the reaction of dietary/salivary nitrites with gastric acid
[9], and the in vitro synthesis of nitrites in the solution con-
taining L-arginine (10^20 mM) and hydrogen peroxide (10^50
mM) [12].
The present study was aimed at verifying if SW treatment
elicits the non-enzymatic production of NO even under milder
conditions than those previously described. Indeed, we per-
formed the experiments at physiological pH in the presence
of the amounts of H2O2 lower than those used by Nagase et
al. [12] and in a shorter time (8 min) than that used in their
system (up to 5 days) [12].
2. Materials and methods
2.1. Materials
L-Arginine, L-citrulline, glycine, urea were from Fluka; H2O2 was
from Carlo Erba; nitrate reductase was from Roche; glutamate de-
hydrogenase from Boehringer, HCl from Merck; NaOH, sodium
phosphate (NaP), ammonium acetate, K-ketoglutarate, naphtylethyl-
enediamine dihydrochloride, sulfanilamide, carbon disul¢de, N-meth-
yl-D-glucamine and ferrous sulfate were from Sigma. N-methyl-D-gluc-
amine dithiocarbamate (MGD) sodium salt was synthesized by the
method of Shinobu et al. [13]. Stock solutions of Fe2þ^(MGD)2
were prepared by dissolving MGD sodium salt and ferrous sulfate
in nitrogen-purged double distilled water, molar ratio 5:1.
2.2. SW treatment
An electromagnetic MODULITH SLK SW device (provided by
Storz Medical AG) was used throughout. The instrument was
equipped with a support for Greiner 2-ml test-tubes, to allow for
the correct alignment of the focal point with the test-tube. All experi-
ments were performed in solutions bu¡ered to pH 7 with NaP.
Samples were thermally regulated at 37‡C before and during the
SW treatments (500^2000 SW shots; two shots/s, so the time course
ranged between 4 min 10 s and 32 min), and put in ice after the end of
the treatment, to stop the course of the reaction, and kept at 320‡C
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or in liquid nitrogen until use. The blank samples (without SW treat-
ment) were thermally treated in the same way.
2.3. Spectroscopic measurement of NO32 and NO
3
3
Nitrites, NO32 , were determined either spectrophotometrically with
the Griess reactant [14], forming a colored product that can be opti-
cally detected at 541 nm, or £uorometrically, following the formation
of a £uorescent product, due to the reaction of NO32 with 2,3-diami-
nonaphthalene (DAN) [15,16]. Nitrates, NO33 , were determined with
the Griess reagent [14] after their enzymatic reduction to nitrites.
2.4. Measurement of NO
NO was measured by the spin trapping technique, using the Fe2þ^
(MGD)2 complex [17]. Brie£y, 2 mM Fe2þ^(MGD)2 (¢nal concentra-
tion expressed in terms of iron content) was added to the incubation
mixtures just before performing the SW treatment. The mixtures were
immediately frozen at the end of the experiment and lyophilized. They
were then redissolved in a smaller volume to increase sensitivity, and
EPR spectra were recorded at 100 K to observe the typical nitrosyl^
iron triplet signal arising from trapped 14NO. X-band EPR spectra
were measured on a Bruker EMX spectrometer at the Nicox Research
Institute, Bresso, Milan, Italy.
3. Results and discussion
To evaluate the non-enzymatic synthesis of NO elicited by
SW treatment, solutions containing 1^10 mM L-arginine and
0.1^10 mM H2O2 were treated with 1000 shots of SW, and
nitrite levels in the solution were estimated by a £uorometric
method [16]. The rationale for choosing millimolar concentra-
tions of H2O2 is based on the assumption that hydrogen per-
oxide transiently rises to such levels during in£ammatory
events, as it can be deduced by several data existing in the
literature [18], although H2O2 is rapidly dismutated by cata-
lase under physiological conditions. As shown in Table 1, SW
elicited a rapid (8 min of SW treatment) and signi¢cant pro-
duction of nitrites (86R 21 nM) only in the solution contain-
ing 10 mM L-arginine and 1 mM H2O2 (sample 4), suggesting
that SW treatment could lead to the non-catalytic synthesis of
physiopathologically relevant amounts of NO under appropri-
ate conditions. It should be noted that these conditions are far
milder than those tested by Nagase et al. [12] and may more
reliably mimic the early phase of an acute in£ammatory pro-
cess.
In order to determine the entire production of NO, nitrates
were estimated after their enzymatic reduction to nitrites.
Since the £uorometric standard measurements gave no repro-
ducible results, probably because of the presence of a ‘quench-
er’ in the system used, the estimation of nitrites plus nitrates
was made with the Griess method [14]. Unfortunately, the
Table 1
SW-elicited production of nitrites
Parameters Samples series
1 2 3 4 5
[L-Arg], mM 1 10 1 10 10
[H2O2], mM 0.1 0.1 1 1 10
[NO32 ], nMRS.D. (traces)6 5 (n=10) 11R 5 (n=10) 0 (n=10) 86R 21 (n=15) 0 (n=10)
The amounts of nitrites produced in the solution containing L-arginine and H2O2 were measured by £uorometric method after 1000 shots of
SW at the energy level of 0.89 mJ/mm2. n=number of experiments.
Fig. 1. EPR spectra of a solution of (A) 1 mM H2O2, 2 mM Fe2þ^
(MGD)2 ; (B) 10 mM L-arginine, 1 mM H2O2, 2 mM Fe2þ^
(MGD)2 ; (C) 10 mM L-arginine, 1 mM H2O2, 2 mM Fe2þ^
(MGD)2 after treatment with SW (1000 shots, 0.89 mJ/mm2). EPR
settings were: frequency, 9.31 GHz; microwave power, 1 mW; mod-
ulation amplitude, 2 G; temperature, 100 K.
Fig. 2. Production of nitrites in the the presence of 10 mM L-argi-
nine and 1 mM H2O2 at constant number (1000) of shots of in-
creasing energy levels of SW (A), and at constant energy (0.89 mJ/
mm2) of increasing number of shots (B). The experiments were per-
formed using three identical samples for each condition tested (trip-
licate measurements/sample). Standard deviations were comprised in
the range of 8.5^19.4%, for all values.
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spectrophotometric assay turned out to be not enough sensi-
tive to detect the production of nitrites.
A direct production of nitrites from arginine without the
intermediate formation of NO could not be ruled out a priori
under our experimental conditions. Therefore, the experiment
was also performed in the presence of Fe2þ^(MGD)2, an es-
tablished water-soluble NO spin trap. As shown in Fig. 1, a
signal centered at g=2.037 and with a de¢nite triplet line-
shape, typical of the nitrosyl adduct between 14NO and
Fe2þ^(MGD)2 [19] was observed in the sample containing
10 mM L-arginine and 1 mM H2O2 and subjected to SW
treatment (Fig. 1C). On the other hand, only a very weak
resonance was measured in the absence of SW treatment
(Fig. 1B), and no signal at all was present when L-arginine
was omitted from the mixture (Fig. 1A).
To further investigate if NO could be formed not only from
L-arginine but also from other potential nitrogen donors, so-
lutions containing 10 mM L-citrulline, L-valine, glycine or
urea were treated, in the presence of 1 mM H2O2, with
1000 shots of SW at the highest energy level (0.89 mJ/mm2).
The results obtained indicated that SW treatment was unable
to produce detectable amounts of nitrites in any of these so-
lutions (data not shown). Given that the presence of nitrites
reveals the formation of NO, we can conclude that SW-elic-
ited production of NO appears to require, as does NOS,
L-arginine as a speci¢c nitrogen donor. The understanding
of the chemical pathways leading to the non-enzymatic syn-
thesis of NO from L-arginine in the presence of H2O2 after
SW treatment awaits further elucidation.
Finally, the estimation of non-enzymatic formation of NO
was performed in the solution containing 10 mM L-arginine
and 1 mM H2O2 to study the e¡ect caused by applying
(i) di¡erent SW energy levels, keeping constant the number
of shots (1000), and (ii) di¡erent number of shots, at constant
SW energy level (0.89 mJ/mm2). As shown in Fig. 2, SW
treatment elicited energy-dependent production of nitrites
(Fig. 2A), and SW-elicited production of nitrites increased
in dependence on the number of shots up to 1500 (Fig. 2B).
The present study demonstrates that the £uorometric DAN
method is sensible enough to estimate the concentrations of
nitrites up to 10 nM, and that SW treatment elicits a rapid
(8 min of treatment) production of NO (as unequivocally
shown by EPR) in the solution containing 10 mM L-arginine
and 1 mM H2O2. The estimated amounts of nitrites (86^108
nM) are compatible with those of NO under physiopatholog-
ical conditions, although this value should probably be under-
estimated, because of the possible transformation of nitrites to
nitrates during the experimental process. These data are, on
the one hand, in line with those reported by Nagase et al. [11],
indicating the non-catalytic synthesis of NO in the solution
containing L-arginine and H2O2. On the other hand, they have
been obtained under far milder experimental conditions (high-
er concentration in both L-arginine and H2O2) than the results
of Nagase et al. [12].
In conclusion, SW treatment, under conditions mimicking
physiopathological situations (i.e. 10 mM L-arginine and
1 mM H2O2), induced non-enzymatic production of physiol-
ogically relevant amounts of NO (108R 16 nM, 1500 shots at
the highest energy applied in 12.5 min, see Fig. 2B), as a
function of both the number of shots and the applied energy
levels. Therefore, the results presented here, even if obtained
by using an extremely simpli¢ed in vitro system, may repre-
sent, mutatis mutandis, a ¢rst step to understand the biochem-
ical events that underlie the clinically observed bene¢cial ef-
fects of SW treatment in some in£ammatory syndromes.
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